Trade NKTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Nkarta, Inc. (NKTX) is trading at US$2.85, up 0.71% today as of Sep 21, 09:46 EDT. The company has a market capitalisation of US$190.52M. Over the past 52 weeks, NKTX has traded between US$1.70 and US$3.72. On Syfe you can trade NKTX with $0 commission and add it to your watchlist.
| Previous close | US$2.83 |
|---|---|
| Market cap | US$190.52M |
| 52-week range | US$1.70 – US$3.72 |
| Volume | 609.74K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Nkarta, Inc.
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.
Year: 2020
TD Cowen Initiates Nkarta at Buy
Jun 23, 10:05 AM · MT Newswires
Nkarta Reports FDA Agreement on Outpatient Dosing of NKX019
Apr 15, 8:32 PM · MT Newswires
Nkarta Files $350 Million Mixed Shelf
Mar 25, 9:36 PM · MT Newswires
Nkarta, Inc. (NKTX) stock is trading at US$2.85, +0.71% from the previous close of US$2.83.
The market cap for Nkarta, Inc. (NKTX) stock is approximately US$190.52M.
The 52-week high for Nkarta, Inc. (NKTX) stock is US$3.72.
The 52-week low for Nkarta, Inc. (NKTX) stock is US$1.70.
Nkarta, Inc. (NKTX) does not currently pay a dividend.
Stay on top of NKTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
